realinvestor888 Big sharks want push no choice...abo push last minute on Aug meh???

Today is the 1st day to push until Aug....u imagine how big the room still has....RM20 by Aug.....RM30 by Dec

Harta is biggest cap compared to Topglov, they have better margin, better Nitrile gloves, better businesses in USA, South America & Europe

https://www.cnbc.com/2020/06/30/fauci-says-us-coronavirus-outbreak-is-going-to-be-very-disturbing-could-top-100000-cases-a-day.html

https://www.youtube.com/watch?v=MR73uTTVof0

USA getting worst, new TP for Supermx, RM15 is possible!!!

It just started for Harta, whereby Topglove & Supermx were performed so well in May, July is the month for Harta!!! RM20 easily achievable, TP RM30!!!

The U.S. is “not in total control” of the coronavirus pandemic and daily new cases could surpass 100,000 new infections per day if the outbreak continues at its current pace, White House health advisor Dr. Anthony Fauci said Tuesday.

The country is now reporting nearly 40,000 new coronavirus cases every day — almost double from about 22,800 in mid-May — driven largely by outbreaks in a number of states across the South and West. Fauci said about 50% of all new cases are coming from four states: Florida, California, Texas and Arizona.

“I can’t make an accurate prediction but it’s going to be very disturbing,” Fauci told senators in a hearing held by the Senate Health, Education, Labor and Pensions Committee. “We are now having 40-plus-thousand new cases a day. I would not be surprised if we go up to 100,000 a day if this does not turn around, and so I am very concerned.”

The U.S. is “not in total control” of the coronavirus pandemic and daily new cases could surpass 100,000 new infections per day if the outbreak continues at its current pace, White House health advisor Dr. Anthony Fauci said Tuesday.

The country is now reporting nearly 40,000 new coronavirus cases every day — almost double from about 22,800 in mid-May — driven largely by outbreaks in a number of states across the South and West. Fauci said about 50% of all new cases are coming from four states: Florida, California, Texas and Arizona.

“I can’t make an accurate prediction but it’s going to be very disturbing,” Fauci told senators in a hearing held by the Senate Health, Education, Labor and Pensions Committee. “We are now having 40-plus-thousand new cases a day. I would not be surprised if we go up to 100,000 a day if this does not turn around, and so I am very concerned.”

you call the price, QE will sapu all Nitrile Gloves

USA need Harta Nitrile glove just like their QE "unlimited"

https://www.youtube.com/watch?v=MR73uTTVof0

Dr. Anthony Fauci says U.S. coronavirus outbreak is ‘going to be very disturbing,’ could top 100,000 new cases a day

https://www.cnbc.com/2020/06/30/fauci-says-us-coronavirus-outbreak-is-going-to-be-very-disturbing-could-top-100000-cases-a-day.html

Koon Yew Yin 30 June 2020

This morning I attended Comfort Gloves AGM. The man on my right is the Chairman and the man on my left is the CEO. I wish to record here what the Chairman said at the AGM.


The Chairman publicly said that the continuous demand for gloves far exceeds supply due to the Covid 19 pandemic. As a result, the company can easily increase the sale price for their products. They are increasing their sale price by 5-10 % every month since the beginning of the 2nd quarter. They sell cheaper to the long-term customers and higher prices to the other customers. They have no difficulty in selling even at higher selling prices because the orders are coming in continuously.

The have increased 6 additional production lines recently and they are working 24 hours a day, 7 days a week to produce as many gloves as practical.


The increase of the selling does not cost the company anything. It is pure profit.

9MFY20 PATAMI of RM575m (+98% YoY) came in above expectations at 58%/63% of our/consensus full-year forecasts. The result is deemed above our expectation. The variance from our forecast is due to higher-than-expected margins. Hence, we raised our FY20E/FY21E net profit by 22%/30%, to account for higher margins. TP is raised from RM20.10 to RM25.00 based on unchanged 36x CY21E revised EPS. Reiterate Outperform.

QoQ, 3QFY20 revenue rose 37% due to higher sales volume (+25%) and ASP (+5%). Correspondingly, PBT margin improved by a massive 14.4ppt to 25% compared to 10.6% in 2QFY20 due to higher ASP which theoretically flow straight down to bottom-line as well as gains from greater efficiency and economies of scale. This brings 3QFY20 PATAMI to RM348m (+200%). A 1st interim DPS of 10.0 sen was announced which came in above our expectation.

YoY, 9MFY20 revenue rose 14% due to higher volume sales (+45%) and ASP (+3%). Utilisation shot up from 85% to >95%. Interestingly, Aspion’s capacity was also instrumental in enabling Top Glove to meet the intensified demand driven by revenue (+48%) bringing 9MFY20 net profit which grew four-fold to RM47m, as the Group’s concentrated efforts to improve efficiency, quality and profitability bore fruit. This propelled 9MFY20 PATAMI higher by 98% to RM575m.

Monthly sales remained tight, net cash position restored. Monthly sales orders went up by some 180%, resulting in long lead times, which went up from 40 days to around 400 days, with orders placed now to be delivered only over a year later. As at 31 May 2020, the group entered into a net cash position of RM279m compared with net borrowings in 2QFY20 which enabled the Group to internally fund capex requirements. We highlight that TOPGLOV’s ASP for months of June to Aug is higher by 15% m-o-m further indicating supply tightness that have further propelled ASP higher. In the 3QFY20 results teleconference, management highlighted that 20% of new capacity will be allocated to spot price which is between USD80 to USD100/1,000 pieces. With a diverse customer base, we expect TOPLGOV to have better pricing power and hence potentially higher-than-expected industry average prices.

Capacity expansion include: Factory 7A (operational by end-1Q 2020; 0.4bn pieces), Factory 2B (operational by 1Q 2020; 0.7b pieces), Factory 5A (operational by 1Q 2020; 2.5b pieces), Factory 40 (Phase 1 operational by 2Q 2020 and Phase 2 operational by 3Q 2020; 2.7b and 2.0b pieces), Factory F41 (2Q 2020; 4b pieces) and Factory 8A (by 4Q 2020; 3.5b pieces) to boost the group’s production capacity in 2020 by 11.8b gloves per annum to 81.9b (+17%).

Raised FY20E/FY21E net profit by 22%/30% after raising our FY20/FY21 EBITDA margin assumption from 23%/26%% to 27%/32%.

Reiterate OP. Correspondingly, TP is raised from RM20.10 RM25.00 based on unchanged 36x CY21E revised EPS of 69.20 sen (at slightly above +2.0SD above 5-year historical forward mean). Its merits are: (i) strong management, (ii) the booming gloves market due to the pandemic, and (iii) solid earnings growth averaging 130% per annum compared to FY20E and FY21E PERs of 37x and 24x, respectively.

Outlook. The first 4 lines of Plant 6 (installed capacity of 4.7b pieces) have commenced commercial operations and the remaining 8 lines are expected to be gradually ramped up. Plant 7 is expected to be commissioned by end 2020 or early 2021, which will focus on small orders as well as specialty products with an installed capacity of 2.4b pieces. All in, Plant 5, 6 and 7 will add a total capacity of 12.1b pieces, raising installed capacity to 43.7b pieces per annum.

Raised FY21E/FY22E net profit by 22%/24% after: (i) imputing higher ASP from USD26/1,000 pieces to USD29/1,000 pieces for each year, and (ii) assuming higher EBITDA margin of 26.5% compared to 24% previously.

We like Hartalega for: (i) its solid management, (ii) constantly evolving via innovative products development, and (iii) its booming nitrile gloves segment.


Source: Kenanga Research - 29 May 2020

Q4 QR not included the Plant 6 (total 12 lines, 14.1b pieces), while Plant 7 may be completed earlier due to high demand; which next 1-2 QR would be more explosive up QRs.

Harta shall deserve higher TP than Topglov!!!

ASP in increasing from Mar till today:

https://www.worldometers.info/coronavirus/#countries

As worldwide Covid cases is increasing actually still in wave 1 not even wave 2 (especially for USA), some countries are in the wave 2

Target: RM18.16
https://klse.i3investor.com/servlets/ptres/55867.jsp

The share margin valuation of Hartalega was increased to RM10.52 from RM8.97 previously, Top Glove to RM18 from RM9.41, Supermax to RM7.41 from RM3.38, Rubberex to RM2.21 from 81 sen, and Comfort Gloves to RM3.42 from RM2.29.

https://www.theedgemarkets.com/article/glove-stocks-rebound-amid-worsening-covid19-situation

https://www.worldometers.info/coronavirus/country/us/

Record high in Wave 1, not even start wave 2

Moreover, this windfall tax cannot help much to PN Gov

Winfall tax cannot imposed as PN want the KLSE to be uptrend, if they impose,KLSE will drop, all investors will not support PN anymore

https://www.worldometers.info/coronavirus/country/us/

https://www.facebook.com/Bizlife.asia/videos/585735649028875/

Hold until 2040! World fortune 500, capital gain 40-50 times. Boss committed!!! Small fish, what are you waiting for? Cash out all FD put into Topglov, to get the guarantee exponentially
income growth!

https://www.facebook.com/Bizlife.asia/videos/585735649028875/

Hold until 2040! World fortune 500, capital gain 40-50 times. Boss committed!!! Small fish, what are you waiting for? Cash out all FD put into Topglov, to get the guarantee exponentially
income growth!

https://www.facebook.com/Bizlife.asia/videos/585735649028875/

it will not fluctuate much till next QR, but once QR out it will fly, so this is best chance to entered now before next QR

it will not fluctuate much till next QR, but once QR out it will fly, so this is best chance to entered now before next QR

it will not fluctuate much till next QR, but once QR out it will fly, so this is best chance to entered now before next QR

it will not fluctuate much till next QR, but once QR out it will fly, so this is best chance to entered now before next QR

https://covid19.who.int/region/amro/country/us

USA is the largest customer base of Harta

https://covid19.who.int/region/amro/country/us

USA cases actually still in wave 1,which cases back to peak as per April

will Topglov loss the acquisition to MQT? Very low possibility

https://covid19.who.int/region/amro/country/us

USA cases actually still in wave 1,which cases back to peak as per April

https://covid19.who.int/region/amro/country/us

USA cases actually still in wave 1,which cases back to peak as per April

https://www.chinapress.com.my/20200619/%e2%97%a4%e5%85%a8%e7%90%83%e5%a4%a7%e6%b5%81%e8%a1%8c%e2%97%a2-%e7%a0%94%e7%a9%b6%ef%bc%9a%e6%9f%93%e7%96%ab%e5%ba%b7%e5%a4%8d%e5%90%8e-%e6%8a%97%e4%bd%93%e6%81%90%e5%8f%aa%e7%bb%b4%e6%8c%812/

Long term investors will sapu phase by phase now.

Now just filter off those genting & 4D kaki,after this would be v-shape rebound....cheers

good chance to buy more for real investors...

All genting & 4D kaki getting out, after this would be V-Shapre rebound for real investors....

All gambling kaki, gogogo, get out......

No lah, now filter off the Genting & 4D kaki, after they all out, then will be V-Shape rebound

TY Yap, new TP for Harta, above rm20+

UOB top pick is Topglove, 2nd is Supermax!!! Latest report from bank.

https://research.sginvestors.io/2020/06/rubber-gloves-malaysia-uob-kay-hian-research-2020-06-17.html?m=1

For syariah approval, the classic example would be Penta. When it was delisted from syariah, price down more than 10%, but this yr got the syariah approval again, so up 10%, more or less.

But for Supermx case, as it is hot cake now, it may up 15-20% on 22nd June

While most analysts are positive on Supermax -- eight of the 10 tracked by Bloomberg recommend buying the stock, and none advises to sell, according to a Maybank Investment Bank Bhd. report by Lee Yen Ling last week.

https://www.smh.com.au/business/the-economy/the-first-covid-19-vaccines-may-not-prevent-infection-with-coronavirus-20200616-p552yy.html

Vaccine not easy to officially can be used for public till 2H 2021. Even after 2H 2021, The first COVID-19 vaccines may not prevent infection with coronavirus, it may cure doesn't mean it can prevent!!!

The vaccine is still in clinical trials. If the trial results convince regulators the vaccine is safe and effective. H1N1 case, when vaccine is confirmed ok, the needs of glove still carry on for 3-4 QRs. Now just in trial status, at least 6-7 QRs to go up.

H1N1 record, even got vaccine, they still need the glove for at least 3-4 QRs

The vaccine is still in clinical trials. If the trial results convince regulators the vaccine is safe and effective. Every company claim they got vaccine, but all in trial status, still long way to go

Even though got vaccine, the world has to follow the New Normal sop, more places need to wear gloves at least for their staff. Just like hospital, staff wearing gloves, patients no need.

How big is the new market for glove, I can't imagine

https://klse.i3investor.com/m/blog/gloveharicut/2020-06-11-story-h1508753308-TOPGLOVE_Slide_ALL_GLOVE_SHAREHOLDER_MUST_READ.jsp